Humacyte, Inc. - SIC # 3850 -

Ticker Exchange SIC # Website Latest Ticker
HUMA Nasdaq 3850 www.humacyte.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Humacyte, Inc.

Humacyte (HUMA) Stock Fair Value Moves Lower After Analyst Target Cuts - Oct 8th, 2026 11:16 pm
Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls - Oct 7th, 2026 8:00 am
Humacyte, Inc. (HUMA) Stock Slides as Market Rises: Facts to Know Before You Trade - Oct 6th, 2026 3:00 pm
Humacyte, Inc. (HUMA) Stock Drops Despite Market Gains: Important Facts to Note - Oct 1st, 2026 3:15 pm
Humacyte Expands Board Expertise with Appointment of Scott Coward and Paul Kuznik - Sep 28th, 2026 6:00 am
Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why - Sep 25th, 2026 3:00 pm
Humacyte, Inc. (HUMA) Beats Stock Market Upswing: What Investors Need to Know - Sep 18th, 2026 4:00 pm
Is Humacyte, Inc. (HUMA) a Buy as Wall Street Analysts Look Optimistic? - Sep 17th, 2026 7:30 am
Humacyte to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Sep 10th, 2026 6:00 am
Humacyte Announces FDA Authorization Extending Symvess Shelf Life to 36 Months - Sep 9th, 2026 6:00 am
Humacyte Confirms Plans for ATEV Supplemental BLA Filing for Dialysis Access Following FDA Discussions - Aug 24th, 2026 6:00 am
Humacyte (HUMA) Q2 2026 Earnings Call Transcript - Aug 19th, 2026 8:13 am
Humacyte Announces Lancet Digital Health Publication of V007 Phase 3 Hemodialysis Access Trial Results - Aug 19th, 2026 6:00 am
Board-Certified Vascular and Endovascular Surgeon Performs First Commercial Symvess® Implantation; Cites Bioengineered Blood Vessel as “Revolutionary Advancement” - Aug 18th, 2026 6:00 am
Humacyte (HUMA) Faces A Fresh Test As Its $4 Fair Value Narrative Holds - Aug 13th, 2026 3:09 pm
Humacyte (HUMA) Stock Looks Stretched On Book Value Yet Reasonable After A 93% Fall - Aug 13th, 2026 6:09 am
Humacyte (HUMA) Reports Stronger Phase 3 Dialysis Results In Women - Aug 13th, 2026 5:11 am
Humacyte Inc (HUMA) (Q2 2026) Earnings Call Highlights: Strong Trial Results and Strategic ... - Aug 12th, 2026 5:04 pm
Humacyte, Inc. Q2 2026 Earnings Call Summary - Aug 12th, 2026 3:23 pm